Effectiveness and Safety of Immunomodulators with Anti-TNF Therapy in Crohn's Disease

BACKGROUND & AIMS: The benefit of continuing immunomodulators when “stepping up” to anti-tumor necrosis factor (anti-TNF) therapy for Crohn's disease (CD) is uncertain. This study assessed the effectiveness and safety of immunomodulators with anti-TNF therapy in CD. METHODS: We conducted a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Gastroenterol Hepatol
Autors principals: Osterman, Mark T., Haynes, Kevin, Delzell, Elizabeth, Zhang, Jie, Bewtra, Meenakshi, Brensinger, Colleen M., Chen, Lang, Xie, Fenglong, Curtis, Jeffrey R., Lewis, James D.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475667/
https://ncbi.nlm.nih.gov/pubmed/25724699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2015.02.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars